Literature DB >> 15501622

Diabetes in the elderly and in women: cardiovascular risks.

James R Sowers1.   

Abstract

The prevalence of diabetes in the United States is on the rise because of changing characteristics of our population. Ours is an aging population; women who are older than 75 years constitute the fastest growing segment of our population. Our population is increasingly more overweight and sedentary and the numbers of minority persons who have a higher prevalence of obesity and diabetes are on the rise. Currently, at least 17 million persons have known diabetes; another 4 million have the disease but have not been diagnosed. There also is a much larger population-perhaps up to 60 million per-sons-who has the metabolic syndrome. Up to 60% of persons who have essential hypertension have impaired insulin resistance and other characteristics of this syndrome. This article focuses on the metabolic syndrome and diabetes in women and the elderly.

Entities:  

Mesh:

Year:  2004        PMID: 15501622     DOI: 10.1016/j.ccl.2004.06.008

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  4 in total

1.  Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease.

Authors:  Elissa C McIntosh; Daniel A Nation
Journal:  Diabetes Care       Date:  2019-03-04       Impact factor: 19.112

2.  Association between diabetes mellitus and hypertension with anthropometric indicators in older adults: results of the Mexican Health Survey, 2000.

Authors:  S Sánchez-Viveros; S Barquera; C E Medina-Solis; M C Velázquez-Alva; R Valdez
Journal:  J Nutr Health Aging       Date:  2008-05       Impact factor: 4.075

Review 3.  Metabolic syndrome in the elderly.

Authors:  Matthew Bechtold; John Palmer; Joshua Valtos; Catherine Iasiello; James Sowers
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

4.  Gender disparities in the control of cardiovascular risk factors in people with diabetes.

Authors:  Samy I McFarlane; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-07       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.